EMD LEXIGEN
Trademark domain | |
name | is free? |
---|---|
emd-lexigen.com | |
emdlexigen.com |
The "EMD LEXIGEN" trademark, serial number 76354586 , was filed on 27th of December 2001 with a mark drawing code of 1000 and its transaction date is 76354586. The attorney assigned is H. John Campaign, attorney docket number X488-138. Since 31st of December 2009, the document can be found in the L50 law office in the publication and issue section. The date when we last checked the status of this trademark was 09/11/2006.
The corresponded responsible for this trademark is H. JOHN CAMPAIGN, located at GRAHAM, CAMPAIGN P.C, 36 WEST 44TH STREET, SUITE 1300, NEW YORK, NY 10036-8178.The state or country where the trademark was organized is by Merck Kgaa. The legal entity type behing it is a Other (Indicates Entity-Statement should appear)., located at Frankfurter Strabe 250, D-64293 Darmstadt, zip .
GOODS AND/OR SERVICES | |
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
---|---|
U.S. Class | 052 - Detergents and Soaps |
Class Status | 6 - Active |
Status Date | 01/15/2002 |
Primary Code | 005 |
International Class - 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. | |
U.S. Class | 101 - Advertising and Business |
Class Status | 6 - Active |
Status Date | 01/15/2002 |
Primary Code | 042 |
Goods codes | |
GS0051 | Pharmaceutical and biopharmaceutical products for the treatment of cancer, MDS, genetic disorders and immunological disorders; novel protein drugs for use in the area of oncology, immune therapies and for the treatment of metabolic disorders |
GS0421 | Scientific research and development in the area of pharmacy, medicine, biology and genetics, developing treatments for serious and life-threatening diseases as well as broad technology platforms that will lead to new therapies |
FOREGIN REGISTRATION | |
Foreign Filing Date | 12/19/2001 |
---|---|
Foreign Registration Date | 02/13/2002 |
Foreign Expiration Date | 12/31/2011 |
Foreign Application Number | 30171782.6/0 |
Country | DE |
Foreign Registration Number | 30171782 |
PROSECUTION HISTORY | ||||
Date | Description | Type | Code | |
---|---|---|---|---|
09/15/2006 | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | O - Outgoing Correspondence | MAB3 - ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | |
09/11/2006 | ABANDONMENT - AFTER EX PARTE APPEAL | O - Outgoing Correspondence | ABN3 - ABANDONMENT - AFTER EX PARTE APPEAL | |
10/28/2002 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
09/11/2006 | EXPARTE APPEAL TERMINATED | T - TTAB Proceeding | EXPT - EXPARTE APPEAL TERMINATED | |
06/13/2006 | EX PARTE APPEAL-REFUSAL AFFIRMED | T - TTAB Proceeding | EXPA - EX PARTE APPEAL-REFUSAL AFFIRMED | |
12/06/2005 | EXAMINERS STATEMENT MAILED | O - Outgoing Correspondence | CNES - EXAMINERS STATEMENT MAILED | |
12/04/2005 | EXAMINERS STATEMENT - COMPLETED | R - Renewal | CNES - EXAMINERS STATEMENT - COMPLETED | |
10/05/2005 | JURISDICTION RESTORED TO EXAMINING ATTORNEY | T - TTAB Proceeding | JURT | |
05/19/2005 | ACTION DENYING REQ FOR RECON MAILED | O - Outgoing Correspondence | RECD - ACTION DENYING REQ FOR RECON MAILED | |
05/19/2005 | ACTION CONTINUING FINAL - COMPLETED | S | CNCF - ACTION CONTINUING FINAL - COMPLETED | |
02/18/2005 | PAPER RECEIVED | I - Incoming Correspondence | MAIL - PAPER RECEIVED | |
03/02/2005 | EX PARTE APPEAL-INSTITUTED | T - TTAB Proceeding | EXPI - EX PARTE APPEAL-INSTITUTED | |
03/02/2005 | JURISDICTION RESTORED TO EXAMINING ATTORNEY | T - TTAB Proceeding | JURT | |
03/01/2005 | EXPARTE APPEAL RECEIVED AT TTAB | T - TTAB Proceeding | EXAF - EXPARTE APPEAL RECEIVED AT TTAB | |
08/16/2004 | FINAL REFUSAL MAILED | O - Outgoing Correspondence | CNFR - FINAL REFUSAL MAILED | |
08/16/2004 | FINAL REFUSAL E-MAILED | O - Outgoing Correspondence | GNFR - FINAL REFUSAL E-MAILED | |
02/19/2004 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
02/26/2004 | CASE FILE IN TICRS | O - Outgoing Correspondence | CFIT - CASE FILE IN TICRS | |
02/26/2004 | CASE FILE IN TICRS | O - Outgoing Correspondence | CFIT - CASE FILE IN TICRS | |
02/19/2004 | PAPER RECEIVED | I - Incoming Correspondence | MAIL - PAPER RECEIVED | |
08/15/2003 | NON-FINAL ACTION MAILED | O - Outgoing Correspondence | CNRT - NON-FINAL ACTION MAILED | |
02/28/2003 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
02/28/2003 | PAPER RECEIVED | I - Incoming Correspondence | MAIL - PAPER RECEIVED | |
11/25/2002 | LETTER OF SUSPENSION MAILED | S | CNSL - LETTER OF SUSPENSION MAILED | |
11/20/2002 | EXAMINERS AMENDMENT MAILED | O - Outgoing Correspondence | CNEA - EXAMINERS AMENDMENT MAILED | |
10/28/2002 | Sec. 1(B) CLAIM DELETED | I - Incoming Correspondence | 1.BD - Sec. 1(B) CLAIM DELETED | |
10/28/2002 | PAPER RECEIVED | I - Incoming Correspondence | MAIL - PAPER RECEIVED | |
11/07/2002 | PAPER RECEIVED | I - Incoming Correspondence | MAIL - PAPER RECEIVED | |
04/24/2002 | NON-FINAL ACTION MAILED | F - First Action | CNRT - NON-FINAL ACTION MAILED | |
04/10/2002 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
03/20/2002 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER |
The "EMD LEXIGEN" trademark, serial number 78936880 , was filed on 25th of July 2006 with a mark drawing code of 4000 and its transaction date is 78936880. The attorney assigned is H. John Campaign, attorney docket number X488-280. Since 31st of December 2009, the document can be found in the L90 law office in the publication and issue section. The employee responsible is ALI, STEPHANIE MARIE and the date it was published for opposition on 02/13/2007. The status of this trademark was checked last on 05/09/2008.
Other trademarks by this attorney include , CALCIBON , PHYTODERM , EMAGE . The corresponded responsible for this trademark is H. John Campaign, located at GRAHAM, CAMPAIGN P.C., 36 W 44TH ST STE 1201, NEW YORK NY 10036-8106.The state or country where the trademark was organized is by Merck Kgaa. The legal entity type behing it is a Other (Indicates Entity-Statement should appear)., located at Frankfurter Strasse 250, D-64293 Darmstadt, zip .
GOODS AND/OR SERVICES | |
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
---|---|
U.S. Class | 052 - Detergents and Soaps |
Class Status | 6 - Active |
Status Date | 07/28/2006 |
Primary Code | 005 |
International Class - 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. | |
U.S. Class | 101 - Advertising and Business |
Class Status | 6 - Active |
Status Date | 07/28/2006 |
Primary Code | 042 |
Goods codes | |
GS0051 | House mark for pharmaceutical and biopharmaceutical products for the treatment of cancer, MDS, genetic disorders and immunological disorders; novel protein drugs for use in the area of oncology, immune therapies and for the treatment of metabolic disorders |
GS0421 | House mark for scientific research and development in the area of pharmacy, medicine, biology and genetics, developing treatments for serious and life-threatening diseases as well as broad technology platforms that will lead to new therapies |
PROSECUTION HISTORY | ||||
Date | Description | Type | Code | |
---|---|---|---|---|
11/22/2006 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
11/08/2007 | EXTENSION 1 GRANTED | S | EX1G - EXTENSION 1 GRANTED | |
08/08/2008 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | O - Outgoing Correspondence | MAB6 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | |
08/08/2008 | ABANDONMENT - NO USE STATEMENT FILED | S | ABN6 - ABANDONMENT - NO USE STATEMENT FILED | |
11/08/2007 | EXTENSION 1 FILED | S | EXT1 - EXTENSION 1 FILED | |
11/08/2007 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
05/08/2007 | NOA MAILED - SOU REQUIRED FROM APPLICANT | O - Outgoing Correspondence | NOAM - NOTICE OF ALLOWANCE-MAILED | |
02/13/2007 | PUBLISHED FOR OPPOSITION | A - Allowance for Publication | PUBO - PUBLISHED FOR OPPOSITION | |
01/24/2007 | NOTICE OF PUBLICATION | O - Outgoing Correspondence | NPUB - NOTICE OF PUBLICATION | |
12/26/2006 | LAW OFFICE PUBLICATION REVIEW COMPLETED | O - Outgoing Correspondence | PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED | |
12/23/2006 | APPROVED FOR PUB - PRINCIPAL REGISTER | P | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
11/22/2006 | AMENDMENT FROM APPLICANT ENTERED | I - Incoming Correspondence | ACEC - AMENDMENT FROM APPLICANT ENTERED | |
11/06/2006 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
11/06/2006 | PAPER RECEIVED | I - Incoming Correspondence | MAIL - PAPER RECEIVED | |
09/28/2006 | NON-FINAL ACTION E-MAILED | F - First Action | GNRT - NON-FINAL ACTION E-MAILED | |
09/28/2006 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
09/28/2006 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
07/28/2006 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM |
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.